Reducing risk for developing melanoma and other skin cancers

Compared with most other cancers, rates of melanoma and other skin cancers continue to increase, especially in young people. Skin cancer risk increases in those who intentionally tan, and those who do not consistently use sun protection strategies when they are out in the sun. Our projects use innovative strategies for communicating skin cancer risks using genetic information that is relevant to the general population, including those with a range of skin types. Our goal is to understand the processes by which individuals use this information to enhance their motivation for sun protection and avoidance of tanning.

Utilizing Novel Public Health Genomics Approaches to Reducing Skin Cancer Risk in the Population

The preponderance of research on translational genomics has focused on the highest risk individuals and families, and in tertiary care settings with advanced clinical genetics expertise. Our work in primary care and other general population samples have investigated the opportunities of using information about skin cancer genetic susceptibility to motivate sun protection and screening behavior in racially and ethnically diverse populations. Our work has revealed that Albuquerque, New Mexico primary care patients are quite interested in skin cancer genetic information, is understood by those across a range of education and health literacy levels, and that such information can motivate enhanced sun protection and skin cancer screening, particularly among those who are less aware of their skin cancer risk. We are currently examining the use of such testing in higher risk college students in Salt Lake City Utah, as well as in Federally Qualified Health Centers in Tampa, Florida. This work has served as a model for anticipated implementation of skin cancer genetic testing into behavioral interventions for skin cancer prevention across diverse primary care networks.

  • Sutton SK, Turner K, Chung-Bridges K, Vadaparampil ST, Abdulla R, Arevalo M, Avrilien N, Byrne MM, Endemano E, Garcia Hernandez J, Hamilton JG, Lyjak E, Parrales Z, Ramos J, Torres M, White B, Hay JL, Kanetsky PA. A hybrid effectiveness-implementation trial to integrate precision skin cancer risk feedback in federally qualified health centers. Contemp Clin Trials. 2026 Aug 14;169:108439. PMCID: PMC13527874.
  • Hay JL, Kaphingst KA, Buller D, Schofield E, Meyer White K, Sussman A, Guest D, Dailey YT, Robers E, Schwartz MR, Li Y, Hunley K, Berwick M. Behavioral and psychological outcomes associated with skin cancer genetic testing in Albuquerque primary care. Cancers. 2021; 13(16):4053. 
  • Bowers JM, Acevedo AM, Hay JL. Development of a scale to assess multidimensional aspects of unintentional tanning. J Health Psychol. 2026 Mar 29:13591053261429778. Epub ahead of print. PMID: 41906437.

Examining Melanoma Treatment Decision Making

While oncology treatment choices largely center around physician recommendations, the treatments of some cancers require increasing decision making input from patients themselves. I work closely with the MSK Melanoma Disease Management team to identify novel precursors and quality of life outcomes related to melanoma patients’ decisions regarding the use of immunotherapy in the adjuvant setting. We have also clarified patient preferences regarding consenting for clinical photography, and specified the value of patient reported outcomes in the dermatology setting. This research contributes to national efforts (e.g., National Cancer Institute, American Society of Clinical Oncology) calling for increased integration of patient’s values and preferences, including patient reported outcomes, into oncology treatment. 

  • Atkinson TM, Hay JL, Young Kim S, Schofield E, Postow MA, Momtaz P, Warner AB, Shoushtari AN, Callahan MK, Wolchok JD, Li Y, Chapman PB. Decision-Making and Health-Related Quality of Life in Patients with Melanoma Considering Adjuvant Immunotherapy. Oncologist. 2023;28(4):351-357. PMCID: PMC10078893.
  • Marchetti MA, Sar-Graycar L, Dusza SW, Nanda JK, Kurtansky N, Rotemberg VM, Hay JL. Prevalence and age-related patterns in health information seeking behaviors and technology use among skin cancer survivors: Survey study. JMIR Dermatology. 2022;5(2):e36256. PMCID: PMC9910806
  • Sar-Graycar L, Rotemberg VM, Matsoukas K, Halpern AC, Marchetti MA, Hay JL. Interactive skin self-examination digital platforms for the prevention of skin cancer: A narrative literature review. Journal of the American Academy of Dermatology. 2020;84(5):1459-1468. PMCID: PMC7796926.